Congressman Hakeem Jeffries

Yesterday, Representative Jeffries introduced the bipartisan “Terminating the Extension of Rights Misappropriated” (TERM) Act of 2019. This legislation would address the rising cost of prescription drugs by significantly limiting the process known as “evergreening”, whereby pharmaceutical companies make minor changes to a drug and file for a new patent on those trivial changes in order to extend their exclusivity and maintain high prices.

The bipartisan CASE Act establishes the Copyright Claims Board at the Copyright Office to make it easier and less expensive for independent creators, such as photographers, songwriters and graphic artists, to better defend their intellectual property from theft.

The Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act seeks to curb the abuse of the Food and Drug Administration’s (FDA) petition process while preserving the opportunity to submit legitimate claims raising public health concerns